Literature DB >> 13845884

The probable role of benign histoplasmosis in the etiology of granulomatous uveitis.

A C WOODS, H E WAHLEN.   

Abstract

Entities:  

Keywords:  HISTOPLASMOSIS/complications; UVEITIS/etiology

Mesh:

Year:  1960        PMID: 13845884     DOI: 10.1016/0002-9394(60)91515-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  14 in total

1.  Alan C. Woods, Sr., M.D. A giant in his time.

Authors:  D L Knox
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

2.  Acute presumed histoplasmosis of the optic nerve head.

Authors:  R C Husted; J P Shock
Journal:  Br J Ophthalmol       Date:  1975-08       Impact factor: 4.638

3.  Presumed ocular histoplasmosis in The Netherlands--an area without histoplasmosis.

Authors:  M S Suttorp-Schulten; J G Bollemeijer; P J Bos; A Rothova
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

4.  Histoplasmosis in Southern Ontario: a further report.

Authors:  E L BROWN
Journal:  Can Med Assoc J       Date:  1962-09-08       Impact factor: 8.262

5.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1961-03-18

6.  Presumed ocular histoplasmosis syndrome and linear streak lesions.

Authors:  F G Bottoni; A F Deutman; A L Aandekerk
Journal:  Br J Ophthalmol       Date:  1989-07       Impact factor: 4.638

7.  Focal choroidopathy in experimental ocular histoplasmosis.

Authors:  V G Wong
Journal:  Trans Am Ophthalmol Soc       Date:  1972

Review 8.  Natural history and reactivation studies of experimental ocular histoplasmosis in a primate model.

Authors:  R E Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1982

9.  De novo lesions in presumed ocular histoplasmosis-like syndrome.

Authors:  S A Miller; T S Stevens; G de Venecia
Journal:  Br J Ophthalmol       Date:  1976-10       Impact factor: 4.638

10.  Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital.

Authors:  R L Smit; G S Baarsma; J de Vries
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.